What are the commitments of the G7 countries to the COVID vaccine? | Coronavirus pandemic news


The pledge to provide hundreds of millions of doses of vaccine to poor countries is seen as an effort to counter China’s expansion of vaccine diplomacy.

The leaders of the Group of Seven have pledged to donate hundreds of millions of doses of COVID-19 vaccine to the poorer countries of the world.

United Nations Secretary-General Antonio Guterres criticized rich countries in February, calling the distribution “extremely unbalanced and unfair” and warning of so-called “vaccine nationalism” and “vaccine hoarding.”

WHO Director-General Tedros Adhanom Ghebreyesus (Tedros Adhanom Ghebreyesus) said the pandemic is continuing due to “shameful inequality” in vaccine distribution.

These commitments are also seen as an effort against China, which is one of the largest economies in the world, but it is not part of the G7.

China has Delivery of vaccines to 66 countries in the form of aidAccording to the state news agency Xinhua, the company also pledged to supply 10 million doses of vaccine to COVAX supported by the Global Alliance for Vaccines and Immunization (GAVI) and the World Health Organization (WHO).

COVAX’s goal is to provide 2 billion doses of vaccine to low-income countries by the end of 2021.

Before making new commitments this week, only 150 million doses were promised to COVAX, which is far below the 250 million doses required at the end of September.

The following are the promises of G7 so far:

United States

US President Joe Biden plans to buy and donate 500 million doses of Pfizer Provide coronavirus vaccines to more than 90 countries. He also called on the democratic countries of the world to do their part to help end the epidemic.

The US drugmaker Pfizer and its German partner BioNTech will provide 200 million doses in 2021 and 300 million doses in the first half of 2022. The US will then distribute to 92 low-income countries and the African Union.

The Pfizer-BioNTech vaccine requires two doses and must be stored at extremely low temperatures.

United Kingdom

British Prime Minister Boris Johnson once said, “The G7 will promise to distribute vaccines to the world by the end of next year, and millions of them will come from excess British stocks.”

The main use in the UK is the AstraZeneca secondary vaccine developed in cooperation with the University of Oxford.

The United Kingdom stated that the leaders of the Group of Seven countries are expected to agree to provide 1 billion doses of vaccine through dose sharing and financing to end the pandemic in 2022.

Johnson has pledged to donate at least 100 million doses of the remaining coronavirus vaccine within the next year, including 5 million doses that will begin in the next few weeks.

AstraZeneca vaccines are cheap and easy to transport, and are a key component of the COVAX program.

US President Joe Biden held talks with British Prime Minister Boris Johnson before the G7 summit in Cabis Bay in Cornwall on Thursday [Kevin Lamarque/Reuters]

European Union-including Germany, France and Italy

European Commission President Ursula von der Lein stated that the EU’s goal is to donate at least 100 million doses of COVID-19 vaccine to low- and middle-income countries by the end of 2021.

These include France and Germany pledged to donate 30 million doses each, and Italy donated 15 million doses.

France also stated that it has donated 184,000 doses of AstraZeneca’s COVID-19 vaccine to Senegal through the COVAX vaccine sharing program.

Japan

Japan has indicated that it will donate approximately 30 million doses of vaccine produced in the country through COVAX.

Japan shipped 1.24 million doses of AstraZeneca vaccine to Taiwan for free last week.

Taiwan, which emerged from the first year of the pandemic, is relatively unscathed Fight the epidemic that started last month.

Canada

Reuters reported that Canada is negotiating to donate excess doses through COVAX, although it has not disclosed any firm commitments to donate or indicate how much it plans to donate.





Source link